AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services.
作者信息
Arnett Donna K, Goodman Richard A, Halperin Jonathan L, Anderson Jeffrey L, Parekh Anand K, Zoghbi William A
出版信息
Circulation. 2014 Oct 28;130(18):1662-7. doi: 10.1161/CIR.0000000000000128. Epub 2014 Sep 11.
Abstract
摘要
相似文献
1
AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services.
Circulation. 2014 Oct 28;130(18):1662-7. doi: 10.1161/CIR.0000000000000128. Epub 2014 Sep 11.
2
AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services.
J Am Coll Cardiol. 2014 Oct 28;64(17):1851-6. doi: 10.1016/j.jacc.2014.07.012. Epub 2014 Sep 11.
3
The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
Circulation. 2014 Sep 30;130(14):1208-17. doi: 10.1161/CIR.0000000000000090. Epub 2014 Aug 4.
4
The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol. 2014 Sep 30;64(13):1373-84. doi: 10.1016/j.jacc.2014.06.001. Epub 2014 Aug 4.
5
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation. 2013 Jan 15;127(2):268-310. doi: 10.1161/CIR.0b013e31827e8e5f. Epub 2012 Dec 10.
6
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol. 2013 Jan 15;61(2):213-65. doi: 10.1016/j.jacc.2012.09.025. Epub 2012 Dec 10.
7
Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Circulation. 2019 Apr 23;139(17):e879-e886. doi: 10.1161/CIR.0000000000000651.
8
American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
J Am Heart Assoc. 2017 May 11;6(5):e005045. doi: 10.1161/JAHA.116.005045.
9
2024 ACC/AHA Key Data Elements and Definitions for Social Determinants of Health in Cardiology: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Data Standards.
Circ Cardiovasc Qual Outcomes. 2024 Oct;17(10):e000133. doi: 10.1161/HCQ.0000000000000133. Epub 2024 Aug 26.
10
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
J Am Coll Cardiol. 2015 Dec 1;66(21):2356-2361. doi: 10.1016/j.jacc.2015.09.034. Epub 2015 Nov 2.
引用本文的文献
1
Impact of Charlson Comorbidity Index on clinical outcomes of patients with non-ST segment elevation acute coronary syndrome: a propensity score matching method.
BMJ Open. 2025 Aug 13;15(8):e097359. doi: 10.1136/bmjopen-2024-097359.
2
A Survey on the Perceptions of Puerto Rican Cardiologists on the Use of Smartwatches and Implantable Loop Recorders.
Cureus. 2025 Jun 7;17(6):e85519. doi: 10.7759/cureus.85519. eCollection 2025 Jun.
3
Multimorbidity in patients with atrial fibrillation and community controls: A population-based study.
J Multimorb Comorb. 2024 Dec 21;14:26335565241310281. doi: 10.1177/26335565241310281. eCollection 2024 Jan-Dec.
4
A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement.
Am J Respir Crit Care Med. 2024 Sep 15;210(6):715-729. doi: 10.1164/rccm.202407-1320ST.
5
Multimorbidity in Atherosclerotic Cardiovascular Disease and Its Associations With Adverse Cardiovascular Events and Healthcare Costs: A Real-World Evidence Study.
J Health Econ Outcomes Res. 2024 Mar 22;11(1):75-85. doi: 10.36469/001c.94710. eCollection 2024.
6
Adherence to antihypertensives in the United States: A comparative meta-analysis of 23 million patients.
J Clin Hypertens (Greenwich). 2024 Apr;26(4):303-313. doi: 10.1111/jch.14788. Epub 2024 Mar 15.
7
Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy.
Arq Bras Cardiol. 2024 Jan;121(1):e20230229. doi: 10.36660/abc.20230229.
8
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
9
Development and Validation of the US Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) Model: Health Disparity and Economic Impact Model.
Med Decis Making. 2023 Oct-Nov;43(7-8):930-948. doi: 10.1177/0272989X231196916. Epub 2023 Oct 16.
10
Impact of a Prior Cancer Diagnosis on Quality of Care and Survival Following Acute Myocardial Infarction: Retrospective Population-Based Cohort Study in England.
Circ Cardiovasc Qual Outcomes. 2023 Jun;16(6):e009236. doi: 10.1161/CIRCOUTCOMES.122.009236. Epub 2023 Jun 20.
本文引用的文献
1
Understanding the context of health for persons with multiple chronic conditions: moving from what is the matter to what matters.
Ann Fam Med. 2014 May-Jun;12(3):260-9. doi: 10.1370/afm.1643.
2
IOM and DHHS meeting on making clinical practice guidelines appropriate for patients with multiple chronic conditions.
Ann Fam Med. 2014 May-Jun;12(3):256-9. doi: 10.1370/afm.1646.
3
A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity.
J Gen Intern Med. 2014 Apr;29(4):670-9. doi: 10.1007/s11606-013-2659-y. Epub 2014 Jan 18.
4
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
5
The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines.
JAMA. 2013 Dec 18;310(23):2503-4. doi: 10.1001/jama.2013.281422.
6
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Circulation. 2013 Oct 15;128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5.
7
Prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010.
Prev Chronic Dis. 2013 Apr 25;10:E65. doi: 10.5888/pcd10.120203.
8
Prevalence of multiple chronic conditions among Medicare beneficiaries, United States, 2010.
Prev Chronic Dis. 2013 Apr 25;10:E61. doi: 10.5888/pcd10.120137.
9
Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases.
PLoS One. 2012;7(8):e41601. doi: 10.1371/journal.pone.0041601. Epub 2012 Aug 3.
10
Consideration of multiple chronic diseases in randomized controlled trials.
JAMA. 2011 Dec 28;306(24):2670-2. doi: 10.1001/jama.2011.1886.
Zotero 插件